Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.

MLA

Brachs, Sebastian, et al. “Inhibition of Citrate Cotransporter Slc13a5/MINDY by RNAi Improves Hepatic Insulin Sensitivity and Prevents Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.” Molecular Metabolism, vol. 5, no. 11, Aug. 2016, pp. 1072–82. EBSCOhost, https://doi.org/10.1016/j.molmet.2016.08.004.

APA

Brachs, S., Winkel, A. F., Tang, H., Birkenfeld, A. L., Brunner, B., Jahn-Hofmann, K., Margerie, D., Ruetten, H., Schmoll, D., & Spranger, J. (2016). Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. Molecular Metabolism, 5(11), 1072–1082. https://doi.org/10.1016/j.molmet.2016.08.004

Chicago

Brachs, Sebastian, Angelika F Winkel, Hui Tang, Andreas L Birkenfeld, Bodo Brunner, Kerstin Jahn-Hofmann, Daniel Margerie, Hartmut Ruetten, Dieter Schmoll, and Joachim Spranger. 2016. “Inhibition of Citrate Cotransporter Slc13a5/MINDY by RNAi Improves Hepatic Insulin Sensitivity and Prevents Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.” Molecular Metabolism 5 (11): 1072–82. doi:10.1016/j.molmet.2016.08.004.